PSMalpha3 TFA is an inhibitor of NF-kappaB p65 and p38 MAPK. PSMalpha3 TFA forms membrane pores and binds to residues of human insulin B chain to inhibit insulin aggregation. PSMalpha3 TFA forms alpha-type amyloid-like fibrils to exert cytotoxic effects, and acts as a functional amyloid virulence determinant of Staphylococcus aureus. PSMalpha3 TFA is applicable to research related to spondyloarthritis, rheumatoid arthritis, insulin-derived amyloidosis, and Staphylococcus aureus infection[1][2][3].
Molecular Weight:
2749.15
Formula:
C130H193F3N28O32S
Target:
NF-kappaB,p38 MAPK
Application Notes:
MCE Product type: Peptides
* VAT and and shipping costs not included. Errors and price changes excepted
